Cytokine activation of p38 mitogen-activated protein kinase and apoptosis is opposed by alpha-4 targeting of protein phosphatase 2A for site-specific dephosphorylation of MEK3

Molecular and Cellular Biology

Volumn 27, Issue 12, 2007, Pages 4217-4227

  Prickett, Todd D ^a   Brautigan, David L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMINO ACID; ANISOMYCIN; CASPASE 3; CASPASE 7; HEMAGGLUTININ; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; NOCODAZOLE; PHOSPHOPROTEIN PHOSPHATASE 2A; SERINE; SMALL INTERFERING RNA; SORBITOL; STRESS ACTIVATED PROTEIN KINASE; THREONINE; TUMOR NECROSIS FACTOR ALPHA;

ALPHA 4 GENE; AMINO ACID SEQUENCE; ANOIKIS; APOPTOSIS; ARTICLE; CELL GROWTH; CELL STRAIN COS7; CELL STRAIN HEK293; CELL TRANSFORMATION; DEPHOSPHORYLATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ESSENTIAL GENE; GENE TARGETING; HELA CELL; MICROTUBULE; NUCLEOTIDE SEQUENCE; OPITZ SYNDROME; PHOSPHORYLATION; PRECIPITATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; REACTION ANALYSIS;

ACTININ; ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 7; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GENE TARGETING; GENES, ESSENTIAL; HELA CELLS; HEMAGGLUTININS; HUMANS; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 3; MICROFILAMENT PROTEINS; MICROTUBULE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 14; NOCODAZOLE; NUCLEAR PROTEINS; PEPTIDES; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN STRUCTURE, TERTIARY; RNA, SMALL INTERFERING; THREONINE; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34250209867     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00067-07     Document Type: Article

References (55)

1. Aggarwal, B. B. 2003. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3:745-756.
2. Altieri, D. C. 2006. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr. Opin. Cell Biol. 18:609-615.
3. Avdi, N. J., K. C. Malcolm, J. A. Nick, and G. S. Worthen. 2002. A role for protein phosphatase-2A in p38 mitogen-activated protein kinase-mediated regulation of the c-Jun NH(2)-terminal kinase pathway in human neutrophils. J. Biol. Chem. 277:40687-40696.
4. Bao, Q., and Y. Shi. 2006. Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ. 14:56-65.
5. Beck, T., and M. N. Hall. 1999. The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors. Nature 402:689-692.
6. Cai, B., S. H. Chang, E. B. Becker, A. Bonni, and Z. Xia. 2006. p38 MAP kinase mediates apoptosis through phosphorylation of BimEL at Ser-65. J. Biol. Chem. 281:25215-25222.
7. Chen, J., R. T. Peterson, and S. L. Schreiber. 1998. α4 associates with protein phosphatases 2A, 4 and 6. Biochem. Biophys. Res. Commun. 247:827-832.
8. Chen, Z., T. B. Gibson, F. Robinson, L. Silvestro, G. Pearson, B. Xu, A. Wright, C. Vanderbilt, and M. H. Cobb. 2001. MAP kinases. Chem. Rev. 101:2449-2476.
9. Cheung, P. Y., Y. Zhang, J. Long, S. Lin, M. Zhang, Y. Jiang, and Z. Wu. 2004. p150(Glued), Dynein, and microtubules are specifically required for activation of MKK3/6 and p38 MAPKs. J. Biol. Chem. 279:45308-45311.
10. Chung, H., A. C. Nairn, K. Murata, and D. L. Brautigan. 1999. Mutation of Tyr307 and Leu309 in the protein phosphatase 2A catalytic subunit favors association with the alpha 4 subunit which promotes dephosphorylation of elongation factor-2. Biochemistry 38:10371-10376.
11. De Chiara, G., M. E. Marcocci, M. Torcia, M. Lucibello, P. Rosini, P. Bonini, Y. Higashimoto, G. Damonte, A. Armirotti, S. Amodei, A. T. Palamara, T. Russo, E. Garaci, and F. Cozzolino. 2006. Bc1-2 phosphorylation by p38 MAPK: identification of target sites and biologic consequences. J. Biol. Chem. 281:21353-21361.
12. Di Como, C. J., and K. T. Arndt. 1996. Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases. Genes Dev. 10:1904-1916.
13. Eto, M., A. Karginov, and D. L. Brautigan. 1999. A novel phosphoprotein inhibitor of protein type-1 phosphatase holoenzymes. Biochemistry 38:16952-16957.
14. Farooq, A., and M. M. Zhou. 2004. Structure and regulation of MAPK phosphatases. Cell Signal. 16:769-779.
15. Gilmore, A. P. 2005. Anoikis. Cell Death Differ. 12(Suppl. 2):1473-1477.
16. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74.
17. Grethe, S., M. P. Ares, T. Andersson, and M. I. Porn-Ares. 2004. p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x(L). Exp. Cell Res. 298:632-642.
18. Grethe, S., and M. I. Porn-Ares. 2006. p38 MAPK regulates phosphorylation of Bad via PP2A-depcndent suppression of the MEK1/2-ERK1/2 survival pathway in TNF-alpha induced endothelial apoptosis. Cell Signal. 18:531-540.
19. Hui, L., Y. Zheng, Y. Yan, J. Bargonetti, and D. A. Foster. 2006. Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D. Oncogene 25:7305-7310.
20. Ichijo, H. 1999. From receptors to stress-activated MAP kinases. Oncogene 18:6087-6093.
21. Inoue, T., D. L. Boyle, M. Corr, D. Hammaker, R. J. Davis, R. A. Flavell, and G. S. Firestein. 2006. Mitogen-activated protein kinase kinase 3 is a pivotal pathway regulating p38 activation in inflammatory arthritis. Proc. Natl. Acad. Sci. USA 103:5484-5489.
22. Inoue, T., D. Hammaker, D. L. Boyle, and G. S. Firestein. 2005. Regulation of p38 MAPK by MAPK kinases 3 and 6 in fibroblast-like synoviocytes. J. Immunol. 174:4301-4306.
23. Inui, S., K. Kuwahara, J. Mizutani, K. Maeda, T. Kawai, H. Nakayasu, and N. Sakaguchi. 1995. Molecular cloning of a cDNA clone encoding a phosphoprotein component related to the Ig receptor-mediated signal transduction. J. Immunol. 154:2714-2723.
24. Inui, S., H. Sanjo, K. Maeda, H. Yamamoto, E. Miyamoto, and N. Sakaguchi. 1998. Ig receptor binding protein 1 (α4) is associated with a rapamycin-sensitive signal transduction in lymphocytes through direct binding to the catalytic subunit of protein phosphatase 2A. Blood 92:539-546.
25. Jacinto, E., B. Guo, K. T. Arndt, T. Schmelzle, and M. N. Hall. 2001. T1P41 interacts with TAP42 and negatively regulates the TOR signaling pathway. Mol. Cell. 8:1017-1026.
26. Janssens, V., and J. Goris. 2001. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353:417-439.
27. Kong, M., C. J. Fox, J. Mu, L. Solt, A. Xu, R. M. Cinalli, M. J. Birnbaum, T. Lindsten, and C. B. Thompson. 2004. The PP2A-associated protein alpha4 is an essential inhibitor of apoptosis. Science 306:695-698.
28. Kuwahara, K., T. Matsuo, J. Nomura, H. Igarashi, M. Kimoto, S. Inui, and N. Sakaguchi. 1994. Identification of a 52-kDa molecule (p52) coprecipitated with the Ig receptor-related MB-1 protein that is inducibly phosphorylated by the stimulation with phorbol myristate acetate. J. Immunol. 152:2742-2752.
29. Letourneux, C., G. Rocher, and F. Porteu. 2006. B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene 1EX-1 and ERK. EMBO J. 25:727-738.
30. Liu, J., T. D. Prickett, E. Elliott, G. Meroni, and D. L. Brautigan. 2001. Phosphorylation and microtubule association of the Opitz syndrome protein Mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit α4. Proc. Natl. Acad. Sci. USA 98:6650-6655.
31. Massiah, M. A., B. N. Simmons, K. M. Short, and T. C. Cox. 2006. Solution structure of the RBCC/TR1M B-box1 domain of human MID1: B-box with a RING. J. Mol. Biol. 358:532-545.
32. Melhuish, T. A., and D. Wotton. 2006. The Tgif2 gene contains a retained intron within the coding sequence. BMC Mol. Biol. 7:2.
33. Meredith, J. E., Jr., B. Fazeli, and M. A. Schwartz. 1993. The extracellular matrix as a cell survival factor. Mol. Biol. Cell. 4:953-961.
34. Millward, T. A., S. Zolnierowcz, and B. A. Hemmings. 1999. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci. 24:186-191.
35. Mumby, M. C., and G. Walter. 1993. Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol. Rev. 73:673-699.
36. Murata, K., J. Wu, and D. L. Brautigan. 1997. B cell receptor-associated protein α4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A. Proc. Natl. Acad. Sci. USA 94:10624-10629.
37. Nanahoshi, M., T. Nishiuma, Y. Tsujishita, K. Hara, S. Inui, N. Sakaguchi, and K. Yonezawa. 1998. Regulation of protein phosphatase 2A catalytic activity by α4 protein and its yeast homolog Tap42. Biochem. Biophys. Res. Commun. 251:520-526.
38. Nanahoshi, M., Y. Tsujishita, C. Tokunaga, S. Inui, N. Sakaguchi, K. Hara, and K. Yonezawa. 1999. Alpha4 protein as a common regulator of type 2A-related serine/threonine protein phosphatases. FEBS Lett. 446:108-112.
39. Park, M. T., J. A. Choi, M. J. Kim, H. D. Um, S. Bae, C. M. Kang, C. K. Cho, S. Kang, H. Y. Chung, Y. S. Lee, and S. J. Lee. 2003. Suppression of extracellular signal-related kinase and activation of p38 MAPK are two critical events leading to caspase-8- and mitochondria-mediated cell death in phytosphingosine-treated human cancer cells. J. Biol. Chem. 278:50624- 50634.
40. Pearson, G., F. Robinson, T. Beers Gibson, B. E. Xu, M. Karandikar, K. Berman, and M. H. Cobb. 2001. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22:153-183.
41. Prickett, T. D., and D. L. Brautigan. 2006. The alpha-4 regulatory subunit exerts opposing allosteric effects on protein phosphatases PP6 and PP2A. J. Biol. Chem. 281:30503-30511.
42. Prickett, T. D., and D. L. Brautigan. 2004. Overlapping binding sites in protein phosphatase 2A for association with regulatory A and alpha-4 (mTap42) subunits. J. Biol. Chem. 279:38912-38920.
43. Roux, P. P., and J. Blenis. 2004. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68:320-344.
44. Santhanam, A., A. Hartley, K. Duvel, J. R. Broach, and S. Garrett. 2004. PP2A phosphatase activity is required for stress and Tor kinase regulation of yeast stress response factor Msn2p. Eukaryot. Cell 3:1261-1271.
45. Schultz, D. R., and W. J. Harrington, Jr. 2003. Apoptosis: programmed cell death at a molecular level. Semin. Arthritis Rheum. 32:345-369.
46. Stefansson, B., and D. L. Brautigan. 2006. Protein phosphatase 6 subunit with conserved Sit4-associated protein domain targets IκBε. J. Biol. Chem. 281:22624-22634.
47. Tanaka, N., M. Kamanaka, H. Enslen, C. Dong, M. Wysk, R. J. Davis, and R. A. Flavell. 2002. Differential involvement of p38 mitogen-activated protein kinase kinases MKK3 and MKK6 in T-cell apoptosis. EMBO Rep. 3:785-791.
48. Trockenhacher, A., V. Suckow, J. Foerster, J. Winter, S. Krauss, H. H. Ropers, R. Schneider, and S. Schweiger. 2001. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat. Genet. 29:287-294.
49. Van Kanegan, M. J., D. G. Adams, B. E. Wadzinski, and S. Strack. 2005. Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt. J. Biol. Chem. 280:36029-36036.
50. Wadgaonkar, R., J. W. Pierce, K. Somnay, R. L. Damico, M. T. Crow, T. Collins, and J. G. Garcia. 2004. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells. Am. J. Respir. Cell Mol. Biol. 31:423-431.
51. Wajant, H., K. Pfizenmaier, and P. Scheurich. 2003. Tumor necrosis factor signaling. Cell Death Differ. 10:45-65.
52. Whitmarsh, A. J., and R. J. Davis. 1996. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74:589-607.
53. Wysk, M., D. D. Yang, H. T. Lu, R. A. Flavell, and R. J. Davis. 1999. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression. Proc. Natl. Acad. Sci. USA 96:3763-3768.
54. Yang, L., Z. Cao, H. Yan, and W. C. Wood. 2003. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res. 63:6815-6824.
55. Zarubin, T., and J. Han. 2005. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15:11-18.